Related Projects
- Developing better tools for diagnosing patients and populations at risk of primaquine induced haemolysis
- Developing serological markers of recent exposure to malaria
- Epidemiological modelling for malaria elimination
- Identifying “hot spots” and “hot pops” with serological surveillance and operational research of high sensitivity tests
- Identifying populations at risk of multidrug resistant malaria
- Impact of declining transmission on malaria treatment outcomes, immunity and risk of rebound
- Molecular surveillance of malaria parasites to inform on local intervention strategies
- Relatedness of successive Plasmodium vivax infections
- Using pharmacogenomics to improve anti-malarial treatment
Related Publications
- Acquisition and longevity of antibodies to Plasmodium vivax pre-erythrocytic antigens in Western Thailand
- Acquisition of antibodies against endothelial protein C receptor-binding domains of Plasmodium falciparum erythrocyte membrane protein 1 in children with severe malaria
- Antibody targets on the surface of Plasmodium falciparum-infected erythrocytes that are associated with immunity to severe malaria in young children
- Asymptomatic Plasmodium vivax infections induce robust IgG responses to multiple blood-stage proteins in a low-transmission region of western Thailand
- Blood-Stage Parasitaemia and Age Determine Plasmodium falciparum and P. vivax Gametocytaemia in Papua New Guinea
- Decreasing malaria prevalence and its potential consequences for immunity in pregnant women
- Force of infection is key to understanding the epidemiology of Plasmodium falciparum malaria in Papua New Guinean children
- Genomic analysis of local variation and recent evolution in Plasmodium vivax
- Genomic epidemiology of artemisinin resistant malaria
- Human antibodies activate complement against Plasmodium falciparum sporozoites, and are associated with protection against malaria in children
- Human antibodies fix complement to inhibit Plasmodium falciparum invasion of erythrocytes and are associated with protection against clinical malaria
- Identification and prioritization of merozoite antigens as targets of protective human immunity to falciparum malaria for vaccine and biomarker development
- Identification of highly-protective combinations of Plasmodium vivax recombinant proteins for vaccine development
- Identity-by-descent analyses for measuring population dynamics and selection in recombining pathogens
- Increasingly inbred and fragmented populations of Plasmodium vivax associated with the eastward decline in malaria transmission across the Southwest Pacific
- Intermittent preventive treatment for malaria in Papua New Guinean infants exposed to Plasmodium falciparum and P. vivax: a randomized controlled trial
- Iron deficiency during pregnancy is associated with a reduced risk of adverse birth outcomes in a malaria-endemic area in a longitudinal cohort study
- Microscopic and submicroscopic Plasmodium falciparum infection, maternal anaemia and adverse pregnancy outcomes in Papua New Guinea: a cohort study
- Modelling the contribution of the hypnozoite reservoir to Plasmodium vivax transmission
- Monitoring Plasmodium falciparum and Plasmodium vivax using microsatellite markers indicates limited changes in population structure after substantial transmission decline in Papua New Guinea
- Nationwide genetic surveillance of Plasmodium vivax in Papua New Guinea reveals heterogeneous transmission dynamics and routes of migration among subdivided populations
- Naturally acquired antibody responses to more than 300 Plasmodium vivax proteins in three geographic regions
- Protective Immunity against Severe Malaria in Children Is Associated with a Limited Repertoire of Antibodies to Conserved PfEMP1 Variants
- Strategies for Understanding and Reducing the Plasmodium vivax and Plasmodium ovale Hypnozoite Reservoir in Papua New Guinean Children: A Randomised Placebo-Controlled Trial and Mathematical Model
- Sulphadoxine-pyrimethamine plus azithromycin for the prevention of low birthweight in Papua New Guinea: a randomised controlled trial
- Sustained Malaria Control Over an 8-Year Period in Papua New Guinea: The Challenge of Low-Density Asymptomatic Plasmodium Infections
- Targets of complement-fixing antibodies in protective immunity against malaria in children
- The efficacy of dihydroartemisininpiperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysis
- The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network
- Ultra-Sensitive Detection of Plasmodium falciparumby Amplification of Multi-Copy Subtelomeric Targets